Mark Smith is the new CEO and chairman of the board at eMed, a developer of PACS and Web-based systems. Smith has held positions as chairman and CEO of several growing companies, most recently the Potomac Group, a holding company for healthcare software
Mark Smith is the new CEO and chairman of the board at eMed, a developer of PACS and Web-based systems. Smith has held positions as chairman and CEO of several growing companies, most recently the Potomac Group, a holding company for healthcare software and services.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.